✦ LIBER ✦

A comparative study on the effects of diet and exercise, metformin and metformin+pioglitazone treatment on NIDDM patients

✍ Scribed by K. T. Augusti; N. P. Sunil; Andrews Abraham; Sajimon Thomas; Varghese Chemmanam

Publisher: Association of Clinical Biochemistry of India
Year: 2007
Tongue: English
Weight: 77 KB
Volume: 22
Category: Article
ISSN: 0970-1915
DOI: 10.1007/bf02913316

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effects on lipids and lipoprot

Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes

✍ D. J. Betteridge; B. Vergès 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 135 KB

Prospective comparative study in NIDDM p

Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles

✍ L. S. Hermann; J -E. Karlsson; Å. Sjöstrand 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 254 KB

Twenty-two NIDDM patients completed an open randomized cross-over study comparing metformin and glibenclamide over 1 year. The drugs had an equivalent effect on glycaemic control, but, in contrast to glibenclamide, metformin reduced body weight. Neither drug affected triglycerides, total- and LDL-ch

Effects of pioglitazone and metformin on

Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes

✍ R. Basu; A. Basu; V. Chandramouli; B. Norby; B. Dicke; P. Shah; O. Cohen; B. R. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 247 KB

Long-term therapy with addition of piogl

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study

✍ D. R. Matthews; B. H. Charbonnel; M. Hanefeld; P. Brunetti; G. Schernthaner 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Long-term efficacy and tolerability of a

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

✍ B. Charbonnel; G. Schernthaner; P. Brunetti; D. R. Matthews; R. Urquhart; M. H. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 244 KB

The effects of rosiglitazone and metform

The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus

✍ Evren Fidan; H. Onder Ersoz; Mustafa Yilmaz; Hulya Yilmaz; Mustafa Kocak; Caner 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 285 KB